XML 93 R20.htm IDEA: XBRL DOCUMENT v3.19.3
Share-Based Compensation
3 Months Ended
Sep. 30, 2019
Share-based Payment Arrangement [Abstract]  
Share-Based Compensation
Share-based Compensation
Farmer Bros. Co. 2017 Long-Term Incentive Plan
As of September 30, 2019, there were 616,166 shares available under the 2017 Plan including shares that were forfeited under the Prior Plans for future issuance.
Non-qualified stock options with time-based vesting (“NQOs”)
One-third of the total number of shares subject to each stock option vest ratably on each of the first three anniversaries of the grant date, contingent on continued employment, and subject to accelerated vesting in certain circumstances.
Following are the assumptions used in the Black-Scholes valuation model for NQOs granted during the three months ended September 30, 2019:

 
 
Three Months Ended September 30, 2019
Weighted average fair value of NQOs
 
$
4.47

Risk-free interest rate
 
1.8
%
Dividend yield
 
%
Average expected term
 
4.7 years

Expected stock price volatility
 
37.0
%


The following table summarizes NQO activity for the three months ended September 30, 2019:
Outstanding NQOs:
 
Number
of NQOs
 
Weighted
Average
Exercise
Price ($)
 
Weighted
Average
Remaining
Life
(Years)
 
Aggregate
Intrinsic
Value
($ in thousands)
Outstanding at June 30, 2019
 
198,049

 
27.35
 
5.25
 
40

Granted
 
223,713

 
13.13
 
 

Exercised
 

 
 
 

Forfeited
 
(68,842
)
 
27.40
 
 

Expired
 
(12,946
)
 
31.70
 
 

Outstanding at September 30, 2019
 
339,974

 
17.82
 
6.12
 
6

Exercisable at September 30, 2019
 
37,283

 
26.33
 
1.71
 
6


The weighted-average grant-date fair value of options granted during the three months ended September 30, 2019 was $4.60. The aggregate intrinsic values outstanding at the end of period in the table above represent the total pretax intrinsic values, based on the Company’s closing stock price of $12.95 at September 30, 2019 and $16.37 at June 29, 2019, representing the last trading day of the respective periods, which would have been received by NQO holders had all award holders exercised their NQOs that were in-the-money as of those dates. The aggregate intrinsic value of NQO exercises in the three months ended September 30, 2019 represents the difference between the exercise price and the value of the Company’s common stock at the time of exercise. NQOs outstanding that are expected to vest are net of estimated forfeitures.
There were no options exercised during the three months ended September 30, 2019. The Company received $0.3 million in proceeds from exercises of vested NQOs during the three months ended September 30, 2018.
At September 30, 2019 and June 30, 2019, respectively, there was $1.4 million and $1.1 million of unrecognized NQO compensation cost. The unrecognized NQO compensation cost at September 30, 2019 is expected to be recognized over the weighted average period of 2.6 years. Total compensation expense for NQOs were $0.1 million for each of the three months ended September 30, 2019 and 2018.
Non-qualified stock options with performance-based and time-based vesting (PNQs”)
The following table summarizes PNQ activity for the three months ended September 30, 2019:
Outstanding PNQs:
 
Number
of
PNQs
 
Weighted
Average
Exercise
Price ($)
 
 
Weighted
Average
Remaining
Life
(Years)
 
Aggregate
Intrinsic
Value
($ in 
thousands)
Outstanding at June 30, 2019
 
229,961

 
26.21
 
 
1.23
 

Granted
 

 
 
 
 

Exercised
 

 
 
 
 

Forfeited
 
(6,212
)
 
32.85
 
 
 

Expired
 
(149,031
)
 
25.05
 
 
 

Outstanding at September 30, 2019
 
74,718

 
27.95
 
 
1.00
 

Exercisable at September 30, 2019
 
53,990

 
26.65
 
 
0.78
 



The aggregate intrinsic values outstanding at the end of each fiscal period in the table above represent the total pretax intrinsic values, based on the Company’s closing stock price of $12.95 at September 30, 2019 and $16.37 at June 29, 2019, representing the last trading day of the respective fiscal periods, which would have been received by PNQ holders had all award holders exercised their PNQs that were in-the-money as of those dates. The aggregate intrinsic value of PNQ exercises in the three months ended September 30, 2019 represents the difference between the exercise price and the value of the Company’s common stock at the time of exercise. PNQs outstanding that are expected to vest are net of estimated forfeitures.
There were no options exercised during the three months ended September 30, 2019. The Company received $38,455 in proceeds from exercises of vested PNQs during the three months ended September 30, 2018.
At September 30, 2019 and June 30, 2019, there was $4.6 thousand and $39.7 thousand, respectively, of unrecognized PNQ compensation cost. The unrecognized PNQ compensation cost at September 30, 2019 is expected to be recognized over the weighted average period of 0.1 years. Total compensation expense related to PNQs in the three months ended September 30, 2019 and 2018 was $13.7 thousand and $0.1 million, respectively.

Restricted Stock
The following table summarizes restricted stock activity for the three months ended September 30, 2019:
Outstanding and Nonvested Restricted Stock Awards:
 
Shares
Awarded
 
Weighted
Average
Grant Date
Fair Value
($)
Outstanding and nonvested at June 30, 2019
 
32,056

 
21.10

Granted
 
7,370

 
13.56

Vested/Released
 

 

Cancelled/Forfeited
 
(757
)
 
31.70

Outstanding and nonvested at March 31, 2019
 
38,669

 
20.22


The total grant-date fair value of restricted stock granted during the three months ended September 30, 2019 was $0.1 million.

At September 30, 2019 and June 30, 2019, there were each $0.3 million of unrecognized compensation cost related to restricted stock. The unrecognized compensation cost related to restricted stock at September 30, 2019 is expected to be recognized over the weighted average period of 0.5 years. Total compensation expense for restricted stock were $0.2 million and $0.1 million, respectively, in the three months ended September 30, 2019 and 2018.


Performance-Based Restricted Stock Units (“PBRSUs”)
The following table summarizes PBRSU activity for the three months ended September 30, 2019:
Outstanding and Nonvested PBRSUs:
 
PBRSUs
Awarded(1)
 
Weighted
Average
Grant Date
Fair Value
($)
Outstanding and nonvested at June 30, 2019
 
51,237

 
27.69

Granted(1)
 
38,080

 
13.13

Vested/Released
 

 

Cancelled/Forfeited
 
(24,254
)
 
27.91

Outstanding and nonvested at September 30, 2019
 
65,063

 
27.57

Expected to vest at September 30, 2019
 

 

_____________
(1) The target number of PBRSUs is presented in the table. Under the terms of the awards, the recipient may earn between 0% and 150% of the target number of PBRSUs depending on the extent to which the Company meets or exceeds the achievement of the applicable financial performance goals.
The total grant-date fair value of PBRSUs granted during the three months ended September 30, 2019 was $0.5 million.

At September 30, 2019 and June 30, 2019, there was $0.7 million and $0.3 million, respectively, of unrecognized PBRSU compensation cost. The unrecognized PBRSU compensation cost at September 30, 2019 is expected to be recognized over the weighted average period of 2.5 years. Total compensation expense for PBRSUs were $32.9 thousand and $82.0 thousand, respectively, for the three months ended September 30, 2019 and 2018.